As COVID-19 shows, older people are particularly vulnerable to infectious diseases. IMI’s VITAL project is studying vaccines and immunity in older adults, to figure out the best strategies to keep people healthier for longer.
IMI’s EHDEN project dramatically demonstrated the power of using clinical data in research by replicating, during a five-day ‘study-a-thon’, the results of a systematic review covering 20 years of research, and a multi-year clinical trial.
Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet. Read IMI Executive Director Dr Pierre Meulien’s perspective on what is needed to tackle antimicrobial resistance.
During the 2014-16 Ebola outbreak in western Africa, public health expert Nicolas Meda of Burkina Faso played a key role in his country’s response to the epidemic. In an interview, he sets out the lessons learnt from the experience.
Advanced therapies feature in new Innovative Medicines Initiative Calls for proposals, along with topics on artificial intelligence; the need for reliable, relevant health information; and ways of incorporating patients’ perspectives into healthcare and cancer clinical trials.
IMI has involved patients in its projects and activities since the beginning. Now, IMI is creating a pool of patient experts to strengthen the role and voice of patients in IMI activities at strategic and operational levels.